Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A MacRae

Showing results (501-510 of 599) with videos related to

Pageof 60
Sort By:
AMIA Joint Summits on Translational Science Proceedings. AMIA Joint Summits on Translational Science|July 2, 2019
Extending i2b2 into a framework for semantic abstraction of EHR to facilitate rapid development and portability of Health IT applicationsKavishwar B Wagholikar, Layne Ainsworth, Vishal P Vernekar, et al.
Cancers|June 2, 2021
DNA Methylation Signatures and the Contribution of Age-Associated Methylomic Drift to Carcinogenesis in Early-Onset Colorectal CancerJihoon E Joo, Mark Clendenning, Ee Ming Wong, et al.
American Journal of Hematology|May 5, 2025
PIEZO1 Activation-Mediated Generation of Transgene-Free Long-Term Hematopoietic Stem CellsGiorgia Scapin, Jennifer L Cillis, Marie C Goulard, et al.
Circulation Research|December 14, 2023
The Role of <i>MAPRE2</i> and Microtubules in Maintaining Normal Ventricular ConductionDavid Y Chiang, Arie O Verkerk, Rachelle Victorio, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 24, 2005
Use of molecular tumor characteristics to prioritize mismatch repair gene testing in early-onset colorectal cancerMelissa C Southey, Mark A Jenkins, Leeanne Mead, et al.
Familial Cancer|January 31, 2026
Germline MLH1 c.-42 C > T is a likely pathogenic variant predisposing to a reduced-penetrance/modified Lynch syndrome phenotype featuring MLH1-methylated cancersDaniel D Buchanan, Rocio Alvarez, Khalid Mahmood, et al.
Circulation|April 18, 2015
Future translational applications from the contemporary genomics era: a scientific statement from the American Heart AssociationCaroline S Fox, Jennifer L Hall, Donna K Arnett, et al.
Familial Cancer|December 8, 2023
Inherited BRCA1 and RNF43 pathogenic variants in a familial colorectal cancer type X familyJames M Chan, Mark Clendenning, Sharelle Joseland, et al.
Nature Communications|June 26, 2015
Caenorhabditis elegans is a useful model for anthelmintic discoveryAndrew R Burns, Genna M Luciani, Gabriel Musso, et al.
Journal of Gastroenterology and Hepatology|June 9, 2016
Tumor testing to identify lynch syndrome in two Australian colorectal cancer cohortsDaniel D Buchanan, Mark Clendenning, Christophe Rosty, et al.
Pageof 60

Showing results (501-510 of 599) with videos related to

Sort By:
Pageof 60
AMIA Joint Summits on Translational Science Proceedings. AMIA Joint Summits on Translational Science|July 2, 2019
Extending i2b2 into a framework for semantic abstraction of EHR to facilitate rapid development and portability of Health IT applicationsKavishwar B Wagholikar, Layne Ainsworth, Vishal P Vernekar, et al.
Cancers|June 2, 2021
DNA Methylation Signatures and the Contribution of Age-Associated Methylomic Drift to Carcinogenesis in Early-Onset Colorectal CancerJihoon E Joo, Mark Clendenning, Ee Ming Wong, et al.
American Journal of Hematology|May 5, 2025
PIEZO1 Activation-Mediated Generation of Transgene-Free Long-Term Hematopoietic Stem CellsGiorgia Scapin, Jennifer L Cillis, Marie C Goulard, et al.
Circulation Research|December 14, 2023
The Role of <i>MAPRE2</i> and Microtubules in Maintaining Normal Ventricular ConductionDavid Y Chiang, Arie O Verkerk, Rachelle Victorio, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 24, 2005
Use of molecular tumor characteristics to prioritize mismatch repair gene testing in early-onset colorectal cancerMelissa C Southey, Mark A Jenkins, Leeanne Mead, et al.
Familial Cancer|January 31, 2026
Germline MLH1 c.-42 C > T is a likely pathogenic variant predisposing to a reduced-penetrance/modified Lynch syndrome phenotype featuring MLH1-methylated cancersDaniel D Buchanan, Rocio Alvarez, Khalid Mahmood, et al.
Circulation|April 18, 2015
Future translational applications from the contemporary genomics era: a scientific statement from the American Heart AssociationCaroline S Fox, Jennifer L Hall, Donna K Arnett, et al.
Familial Cancer|December 8, 2023
Inherited BRCA1 and RNF43 pathogenic variants in a familial colorectal cancer type X familyJames M Chan, Mark Clendenning, Sharelle Joseland, et al.
Nature Communications|June 26, 2015
Caenorhabditis elegans is a useful model for anthelmintic discoveryAndrew R Burns, Genna M Luciani, Gabriel Musso, et al.
Journal of Gastroenterology and Hepatology|June 9, 2016
Tumor testing to identify lynch syndrome in two Australian colorectal cancer cohortsDaniel D Buchanan, Mark Clendenning, Christophe Rosty, et al.
Pageof 60